| The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids G Lachance, K Robitaille, J Laaraj, N Gevariya, TV Varin, A Feldiorean, ... Nature communications 15 (1), 3431, 2024 | 2 | 2024 |
| Prebiotics improve the efficacy of anti-PD1 immunotherapy in bladder cancer by modulating the gut microbiota J Laaraj, G Lachance, PN Kone, T Gris, A Jamshidi, P Toren, Y Fradet, ... NS-AUA 2023 Annual Meeting 17 (10), 2023 | | 2023 |
| Prebiotics improve anti-PD1 immunotherapy efficacy in bladder cancer by modulating the gut microbiota J Laaraj, G Lachance, AP Nadège Kone, Y Fradet, A Bergeron, ... Can Urol Assoc J. 17 (3 S1), S4–S9, 2023 | | 2023 |
| NSAUA 2022 Annual Meeting Abstracts–Oncology II MB Berjaoui CUAJ 16 (10 Suppl 2), S148, 2022 | | 2022 |
| Poster #65. The anti-tumor activity of prebiotics in bladder cancer J Laaraj, G Lachance, AP Nadège Kone, Y Fradet, A Bergeron, ... Can Urol Assoc J 16 (10 S2), S155, 2022 | | 2022 |
| CUA 2022 Annual Meeting Abstracts–Poster Session 7: Oncology–Bladder J Fadel, D Simonyan, V Fradet, Y Fradet, M Lodde, L Lacombe, P Toren CUAJ 16 (6), S73, 2022 | | 2022 |
| MP-7.4. The anti-tumor effect of prebiotics in bladder cancer J Laaraj, G Lachance, AP Nadège Kone, L Mariève, Y Fradet, A Bergeron, ... CUAJ 16 (6 S1), S73–S74, 2022 | | 2022 |
| Abstract P001: The gut microbiome-prostate tumor crosstalk is modulated by dietary polyunsaturated fatty acids J Laaraj, G Lachance, N Gevariya, T Varin, A Feldiorean, F Gaignier, ... Cancer Immunology Research 10 (1_Supplement), P001-P001, 2022 | | 2022 |
| Étude du microbiote intestinal dans le cancer de la prostate : du développement à la réponse aux traitements J Laaraj, J Desrochers-Goyette, G Lachance, JF Pelletier, T Varin, ... CUAJ 15 (11S5), S248, 2021 | | 2021 |
Vincent Fradet, MD, PhD, FRCS(C)Associate Professor, Department of Surgery, Université Laval在 crchudequebec.ulaval.ca 的电子邮件经过验证
